20th anniversary of publication of “Embryonic Stem Cell Lines Derived from Human Blastocysts”

Nov. 6, 2018 will mark the 20th anniversary of publication of “Embryonic Stem Cell Lines Derived from Human Blastocysts.” The seminal paper, published in the journal Science, documented a breakthrough that occurred when researchers, led by James (Jamie) Thomson at the University of Wisconsin-Madison, developed a technique to isolate and grow human embryonic stem cells in cell culture.

All-in-one repair kit makes CRISPR gene editing more precise

A team of researchers led by SCRMC member, Krishanu Saha, a professor of biomedical engineering at the University of Wisconsin–Madison, has made the fix less error-prone and published its approach today (Nov. 23, 2017) in the journal Nature Communications.

SCRMC recognizes 10th anniversary of iPS cells discovery

Nov. 20, 2017, marks the 10th anniversary of announcing the successful derivation of induced pluripotent stem cells from human somatic cells, published by SCRMC faculty member James Thomson, V.M.D., Ph.D., and his team in Science. Thomson continues his many research collaborations on campus and beyond as Director of Regenerative Medicine at the Morgridge Institute for …

WARF announces annual grant figures and Innovation Award winners

At a ceremony honoring several of the year’s most outstanding inventions, the Wisconsin Alumni Research Foundation (WARF) announced that it has granted the university $61.9 million for the 2017-18 academic year. WARF also announced $19 million in grants to the Morgridge Institute for Research.  Combined, WARF’s investment in UW–Madison-based research and education is approximately $80.9 …

UW–Madison to partner in $20 million cell-based therapy center

The National Science Foundation has awarded nearly $20 million to a consortium of universities, including the University of Wisconsin–Madison, to support a new engineering research center that will develop transformative tools and technologies for the consistent, scalable and low-cost production of high-quality living therapeutic cells. Such cells could be used in a broad range of …